Submit manuscript...
Journal of
eISSN: 2374-6947

Diabetes, Metabolic Disorders & Control

Short Communication Volume 13 Issue 1

Whom not to allow fast for people with diabetes during Ramadan

Mehmet Akif Buyukbese

Department of Internal Medicine, School of Medicine, Gaziantep Islam Science and Technology University, Türkiye

Correspondence: Mehmet Akif Buyukbese, Department of Internal Medicine, School of Medicine, Gaziantep Islam Science and Technology University, Gaziantep, Türkiye

Received: December 30, 2025 | Published: January 21, 2026

Citation: Buyukbese MA. Whom not to allow fast for people wıth dıabetes durıng Ramadan. J Diabetes Metab Disord Control. 2026;13(1):4-6. DOI: 10.15406/jdmdc.2026.13.00304

Download PDF

Abstract

Fasting is much appreciated in people with diabetes, however Ramadan intermittent fasting is a special observance being performed one month duration each and every year in muslim populations for religious purposes. International Diabetes Federation Diabetes and Ramadan (IDF-DaR) Alliance group established several guidelines in order to determine risk stratification in this group with respect to the evidence based published data. Epidemiologic reports indicate that both hypoglycaemia and hyperglycaemia are increased. Meanwhile structured pre-ramadan education for people who were willing to fast had less occasions of aforementioned acute complications. Guidelines today advice healthcare professionals not to allow fast for their patients with diabetes if each of the following does occur: unawareness of hypoglycaemia, unstable cardiac condition, GFR less than 30 ml/min, pregnancy, fraility with age over 70 and having loss of cognitive functions.

Keywords: Diabetes, fasting, ramadan, hypoglycaemia, hyperglycaemia, guidelines

Introduction

Fasting had been popular for many with diabetes since obesity is common in this population. Meanwhile for religious purposes, this exercise is much more different since having extra pounds may not become a major concern during one month long holy month Ramadan Journey where fasting converts into feasting1,2 with joyful celebrations during iftar (meal at sunset as dinner). Despite sickness exempts muslim people with diabetes for fasting,3 data from epidemiological studies carried out with multi-national countriers -some approaching even 20- over 80% were willing to fast4 while latest evidence found this prevalance even higher.5–9 Hypoglycaemia and hyperglycaemia are the most common seen acute complications, although both diabetic ketoacidosis (DKA) and hyperosmolar non-ketoketotic state/coma are rare.1,2

International Diabetes Federation Diabetes and Ramadan (IDF-DaR) Alliance group10 published consensus statement 2016 taking into consideration of views and perspectives of diabetologists all around the World for both determination of risk factors for fasting with diabetes as well as whom to say not to allow fast.1 Accumulating evidence with newer drugs11–15 who exercise fasting gave rise to publish another guideline five years later.2 While the most experienced hypoglycaemia is seen in the afternoon before iftar which is the longest period of fasting time, checking blood glucose either through finger-prick testing or continuous glucose monitoring system (CGMS) devices are also updated accordingly to the Ramadan fasting period, such as performing monitoring the glucose during before sahoor (early morning breakfast before starting the fast), after sahoor, in the afternoon (before iftar), after iftar and whenever the patient himself or herself feel unwell.1,2 Apart from this Ramadan structured education had been shown to decrease the risk of hypoglycaemia leading to safe fast.16–24

Meanwhile longer duration of fasting especially in the summer Ramadan (respectfully to the lunar calender), countries located in the northern hemisphere will be fasting more than 16 hrs which will add extra risk score -such as Canada- as a comparison to inhabitants of countries closer the the equator zone.11,25 This will also not only increase the risk of hypoglycaemia26that may present even with anxiety in some27- but also dehydration that may provoke pre-renal azotemia for the vulnerable kidneys.2,25,28

As a respect to recent guidelines which is known as IDF-DaR 2021 guidelines2 risk stratifications are determined with 14 criteria which are 1.Type of diabetes, 2. Duration of diabetes, 3. Frequency of hypoglycaemia, 4. Level of HbA1c, 5.Medications used for lowering the blood glucose, 6. Frequency of Self Monitoring of Blood Glucose (SMBG), 7. Having recent acute emergencies such as DKA. 8. Heart condition (stable/unstable), 9. Kidney function (Lower GFR), 10. Pregnancy, 11. Frailty with age of 70, 12. Heavy physical work, 13. Previous Ramadan experience, 14. Fasting our equal or more than 16 hours. Each criteria is also given points and when sum over 6 points are considered as ‘not-to fast’. Aforementioned parameters are evidence based and the following each solely is accepted to be the reason not allow the fast. These are; a.Unawareness of hypoglycaemia, b. Unstable cardiac condition, c.GFR less than 30 ml/min, d.Pregnancy, e. Fraility with age over 70 having loss of cognitive functions.

Recent evidence suggest avoidance of fasting in diabetics with advanced chronic liver disease and during the first year of liver transplantation29 but not compensated cirrhosis (Child-Pugh A).30 For those with type 1 diabetes31,32 on complex insulin regimens,14,15 diabetologist should be cautious as well, although observance with AI equipped new technologies such as closed wired insulin pumps provided safer fasting in considerable number of people.33 Newer pills and injectables for diabetes management provided promising outcomes during Ramadan intermittent fasting,11–15,30,33–35 even for the elderly.7 Individualized dose adjustments are crucial before fasting through Pre-Ramadan education programs.16,19–21,34 While the third IDF-DaR guideline is on its way, recent publications emphasize the significance of number of microvascular complications at the time Ramadan fasting is being observed.36

Conclusion

In conclusion, many people with diabetes observe religious fasting. Consensus statements with updated guidelines when associated with pre-Ramadan structured education will help guide healthcare professionals during the follow-up of these observance and as well whom not to allow fast

Acknowledgments

Special thanks to Prof Dr Mohamed Hassanein. Through his leadership and many others’s dedication on this project provided fruitful outcomes. Collaboration with the middle-East and North Africa (MENA) and South and Southeast Asia and as well with many other parts of the world, diabetologists being the member of IDF-DaR Alliance served for many people with diabetes for their education leading to safe fasting.

Conflicts of interest

The author declares that there are no conflicts of interest.

References

  1. Hassanein M, Al-Arouj M, Hamdy O, et al. Diabetes and Ramadan: Practical guidelines. Diabetes Res Clin Pract. 2017;126:303–316.
  2. Hassanein M, Afandi B, Ahmedani MY, et al. Diabetes and Ramadan: Practical guidelines 2021. Diabetes Res Clin Pract. Diabetes Res Clin Pract. 2022;185:109185.
  3. Surah Al-Baqarah, 2:185. 2025.
  4. Salti I, Bénard E, Detournay B, et al. A Population-Based Study of Diabetes and Its Characteristics During the Fasting Month of Ramadan in 13 Countries: Results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27(10):2306–2311.
  5. Babineaux SM, Toaima D, Boye KS, et al. Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med. 2015;32:819–828.
  6. Ibrahim M, Ba-Essa EM, Ahmed A, et al. Recommendations for the Management of Diabetes During Ramadan Applying the Principles of the ADA/ EASD Consensus: Update 2025. Diabetes Metab Res Rev. 2025;41(5):e70057.
  7. Hassanein M, Hussein Z, Shaltout I, et al. The DAR 2020 Global survey: Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes. Diabetes Res Clin Pract. 2021;173:108674.
  8. Hassanein M, Ahmedani MY, Shaltout I, et al. Ramadan fasting among adults with type 2 diabetes in five geographically different regions of the world: The DAR 2020 global survey. Diabetes Epidemiology and Management. 2024;16:100229.
  9. Hassanein M, Zainudin SB, Shaikh S, et al. An update on the current characteristics and status of care for Muslims with type 2 diabetes fasting during Ramadan: the DAR global survey 2022. Curr Med Res Opin. 2024;40(9):1515–1523.
  10. International Diabetes Federation Diabetes and Ramadan Alliance group. 2025.
  11. Hassanein M, Buyukbese MA, Malek R, et al. Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study. Diabetes Res Clin Pract. 2020;166:108189.
  12. Hassanein M, Malek R, Shaltout I, et al. SoliRam Study Investigators. Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study. Diabetes Metab Syndr. 2023;17(2):102707.
  13. Hassanein M, Malek R, Al Sifri S, et al. Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis. Diabetes Ther. 2024;15(11):2309–2322.
  14. Hassanein M, Hafidh K, Ahmedani Y, et al. Effect of different insulin regimens on individuals with type 2 diabetes during Ramadan fasting in the DAR Global Surveys of 2020 and 2022. J Diabetes Endocr Pract. 2025.
  15. Büyükbeşe MA. Experiences with Different Types of Insulin for People with Diabetes Who Fast Ramadan. Journal of Health and Biological Sciences. 2025;1(3):103–108.
  16. McEwen LN, Ibrahim M, Ali NM, et al. Impact of an individualized type 2 diabetes education program on clinical outcomes during Ramadan. BMJ Open Diabetes Research and Care. 2015;3(1):e000111.
  17. Ahmedani MY, Alvi SF. Characteristics and Ramadan-specific diabetes education trends of patients with diabetes (CARE): a multinational survey (2014). Int J Clin Pract. 2016;70(8): 668–675.
  18. Ahmedani MY, Ahsan S, Haque MSU. Role of Ramadan specific diabetes education (RSDE); A prospective study. Pak J Med Sci. 2017;33(3):586–593.
  19. Zainudin SB, Abu Bakar KNB, Abdullah SB, et al. Diabetes education and medication adjustment in Ramadan (DEAR) program prepares for self-management during fasting with tele-health support from pre-Ramadan to post-Ramadan. Ther Adv Endocrinol Metab. 2018;908):231–240.
  20. Hassanein M, Abdelgadir E, Bashier A, et al. The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes. Diabetes Res Clin Pract. 2019;150:288–295.
  21. Al-Ozairi E, El Samad A, Al Kandari J, et al. Intermittent fasting could be safely achieved in people with type 1 diabetes undergoing structured education and advanced glucose monitoring. Front Endocrinol (Lausanne). 2019;10:849.
  22. Ahmedani MY, Siddique M. Ramadan study group collaborators. Assessing the awareness and care of people with diabetes related to Ramadan fasting; a-cross sectional study from Pakistan. J Diabetes Metab Disord. 2019;19(1):29–36.
  23. Shaltout I, Zakaria A, Abdelwahab AM, et al. Culturally based pre-Ramadan education increased benefits and reduced hazards of Ramadan fasting for type 2 diabetic patients. J Diabetes Metab Disord. 2020;19(1):179–186.
  24. Oueslati I, Cherif L, Aloui E, et al. Ramadan diurnal intermittent fasting in patients with diabetes: assessment of knowledge, practices, risk of complications, and impact of pre-Ramadan education. J Diabetes Metab Disord. 2024;24(1):9.
  25. Buyukbese MA. Understanding glucose physiology during Ramadan fasting in diabetes mellitus. Fizyoloji Medical Journal. 2026;2(1):1–6.
  26. Buyukbese MA. Hypoglycaemia during fasting: A Narrative Review. Journal of Metabolic Disorders and Diabetes. 2025;3:1–7.
  27. Buyukbese MA. Diabetes and Anxiety. 3rd International Conference on Social Sciences Research. Bridging Cultures, Building Futures: The Role of Social Sciences in a Changing World. July 7-9, 2025. Swabi, Pakistan (oral presentation, virtual). 2025.
  28. Hassanein M, Yousuf S, Ahmedani MY, et al. Ramadan fasting in people with diabetes and chronic kidney disease (CKD) during the COVID-19 pandemic: The DaR global survey. Diabetes Metab Syndr. 2023;17(7):102799.
  29. Emara MH, Soliman H, Said EM,et al. Intermittent fasting and the liver: Focus on the Ramadan World J Hepatol. 2024;16(8):1070–1083.
  30. Rahman MH, Selim S, Afsana F,et al. Safety and effectiveness of tirzepatide during Ramadan fasting: Real-world evidence from patients with type 2 diabetes in Bangladesh. Diabetes Obes Metab. 2025;28(2):1508–1516.
  31. Alamoudi RM, Aljohani NJ, Alfadhli EM, et al. Fasting Ramadan in patients with T1DM - Saudi Arabia versus other countries during the COVID-19 pandemic. Diabetes Metab Syndr. 2023;17(1):102676.
  32. Hassanein M, Alamoudi RM, Kallash MA, et al. Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey. Diabetes Res Clin Pract. 2021;172:108626.
  33. Buyukbese MA. Artificial Intelligence Use In Patients With Diabetes During Ramadan Fasting. Experimental and Applied Medical Science. 2025;6(4):368–378.
  34. Büyükbeşe MA. A Ramadan experience of a patient with newly diagnosed diabetes. TADER (Tip Arastirmalari Dergisi). 2014;12(3):158–159.
  35. Buyukbese MA. Diabetes and Ramadan Fasting. GISTU Journal of Islamic Studies. 2025;6(2):114–121.
  36. Ponirakis G, Hassanein M, Afandi B, et al. Impact of Microvascular Complications on Glycemic Outcomes in People with Type 2 Diabetes Observing Ramadan Fasting. Journal of Diabetes and Endocrine Practice. 2025.
Creative Commons Attribution License

©2026 Buyukbese. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.